News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Vivo Capital VIII, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/11/2022 |
SC 13G/A
| Vivo Capital VIII, LLC reports a 7.4% stake in Harmony Biosciences Holdings, Inc. |
| 02/11/2022 |
SC 13G/A
| Vivo Capital VIII, LLC reports a 0% stake in Crinetics Pharmaceuticals, Inc. |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Vivo Capital VIII, LLC reports a 5.5% stake in Crinetics Pharmaceuticals, Inc. |
| 02/12/2021 |
SC 13G/A
| Vivo Capital VIII, LLC reports a 2.8% stake in Passage Bio, Inc. |
| 06/11/2020 |
SC 13G/A
| Vivo Capital VIII, LLC reports a 2.2% stake in Menlo Therapeutics Inc. |
| 06/11/2020 |
SC 13G/A
| Vivo Capital VIII, LLC reports a 6.8% stake in Crinetics Pharmaceuticals, Inc. |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Vivo Capital VIII, LLC reports a 12.8% stake in Crinetics Pharmaceuticals, Inc. |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 06/27/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/08/2019 |
SC 13G/A
| Vivo Capital VIII, LLC reports a 7.9% stake in Kadmon Holdings, Inc. |
| 08/06/2018 |
SC 13G/A
| Vivo Capital VIII, LLC reports a 7.2% stake in Nabriva Therapeutics plc |
| 06/21/2018 |
SC 13G/A
| Vivo Capital VIII, LLC reports a 6% stake in Kadmon Holdings, Inc. |
| 02/12/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2018 |
SC 13G/A
| Vivo Capital VIII, LLC reports a 11.1% stake in NABRIVA THERAPEUTICS PLC |
| 02/12/2018 |
SC 13G/A
| Vivo Capital VIII, LLC reports a 13.8% stake in BioPharmX Corporation |
| 02/13/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/13/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
|
|